These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9048434)

  • 21. Non-opioid postoperative analgesia.
    Dahl V; Raeder JC
    Acta Anaesthesiol Scand; 2000 Nov; 44(10):1191-203. PubMed ID: 11065198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possible role of NMDA receptors in antinociception induced by rilmenidine in mice in the formalin test.
    Sabetkasaie M; Khansefid N; Ladgevardi MA
    Eur J Pain; 2007 Jul; 11(5):535-41. PubMed ID: 16934506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NMDA-receptor antagonists in neuropathic pain: experimental methods to clinical trials.
    Sang CN
    J Pain Symptom Manage; 2000 Jan; 19(1 Suppl):S21-5. PubMed ID: 10687335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined opioid-NMDA antagonist therapies. What advantages do they offer for the control of pain syndromes?
    Wiesenfeld-Hallin Z
    Drugs; 1998 Jan; 55(1):1-4. PubMed ID: 9463786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antinociceptive mechanisms of dipsacus saponin C administered intracerebroventricularly in the mouse.
    Suh HW; Song DK; Son KH; Wie MB; Lee KH; Jung KY; Do JC; Kim YH
    Gen Pharmacol; 1996 Oct; 27(7):1167-72. PubMed ID: 8981063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting the N-methyl-D-aspartate receptor for chronic pain management. Preclinical animal studies, recent clinical experience and future research directions.
    Fisher K; Coderre TJ; Hagen NA
    J Pain Symptom Manage; 2000 Nov; 20(5):358-73. PubMed ID: 11068158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How do drugs relieve neurogenic pain?
    Karlsten R; Gordh T
    Drugs Aging; 1997 Nov; 11(5):398-412. PubMed ID: 9359025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adrenergic and cholinergic compounds.
    Sanders RD; Maze M
    Handb Exp Pharmacol; 2007; (177):251-64. PubMed ID: 17087126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The NMDA receptor complex: a long and winding road to therapeutics.
    Wood PL
    IDrugs; 2005 Mar; 8(3):229-35. PubMed ID: 15772895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coping with neuropathic pain: do we need more selective analgesic drugs?
    Mattia C
    Curr Pharm Des; 2005; 11(23):2941-3. PubMed ID: 16178754
    [No Abstract]   [Full Text] [Related]  

  • 31. N-methyl-D-aspartate antagonists and neuropathic pain: the search for relief.
    Childers WE; Baudy RB
    J Med Chem; 2007 May; 50(11):2557-62. PubMed ID: 17489572
    [No Abstract]   [Full Text] [Related]  

  • 32. NMDA-Receptor Antagonists: Evolving Role in Analgesia. Proceedings of a meeting. New York City, New York, USA. May 1, 1999.
    J Pain Symptom Manage; 2000 Jan; 19(1 Suppl):S1-64. PubMed ID: 10687330
    [No Abstract]   [Full Text] [Related]  

  • 33. Drugs for the perioperative control of hypertension: current issues and future directions.
    Feneck R
    Drugs; 2007; 67(14):2023-44. PubMed ID: 17883286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A qualitative systematic review of the role of N-methyl-D-aspartate receptor antagonists in preventive analgesia.
    McCartney CJ; Sinha A; Katz J
    Anesth Analg; 2004 May; 98(5):1385-400, table of contents. PubMed ID: 15105220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-methyl-D-aspartate receptor antagonists and channel blockers have different effects upon a spinal seizure model in mice.
    McAllister KH
    Eur J Pharmacol; 1992 Jan; 211(1):105-8. PubMed ID: 1535594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opioid analgesics as noncompetitive N-methyl-D-aspartate (NMDA) antagonists.
    Ebert B; Thorkildsen C; Andersen S; Christrup LL; Hjeds H
    Biochem Pharmacol; 1998 Sep; 56(5):553-9. PubMed ID: 9783723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Role of the GABA-ergic and adrenergic system in transmission and modulation of pain and possibilities of pharmacologic control].
    Dolezal T
    Cesk Fysiol; 2001 May; 50(2):81-7. PubMed ID: 11409353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of NMDA-receptor antagonists in the treatment of chronic pain.
    Hewitt DJ
    Clin J Pain; 2000 Jun; 16(2 Suppl):S73-9. PubMed ID: 10870744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The N-methyl-D-aspartate-receptor antagonist dextromethorphan lacks analgesic effect in a human experimental ischemic pain model.
    Plesan A; Sollevi A; Segerdahl M
    Acta Anaesthesiol Scand; 2000 Sep; 44(8):924-8. PubMed ID: 10981567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interest of alpha2-adrenergic agonists and antagonists in clinical practice: background, facts and perspectives.
    Crassous PA; Denis C; Paris H; Sénard JM
    Curr Top Med Chem; 2007; 7(2):187-94. PubMed ID: 17266605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.